NovoCure Limited (NVCR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 09:32AM EDT. Market open.
| Previous close | 12.34 |
| Open | 12.34 |
| Bid | 12.23 x 200 |
| Ask | 12.49 x 200 |
| Day's range | 12.24 - 12.37 |
| 52-week range | 10.87 - 83.60 |
| Volume | |
| Avg. volume | 1,286,193 |
| Market cap | 1.329B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
NovoCure (NVCR) Moves to Buy: Rationale Behind the Upgrade
NovoCure (NVCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks
NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock?
NovoCure (NVCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Investor's Business Daily
Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish
Novocure stock surged Wednesday after its medtech device nearly doubled the length of time patients with brain tumors lived before worsening.
© 2024 Yahoo. All rights reserved.